Effects of Single-task Versus Dual-task Training on balancePERFORMANCE

NCT ID: NCT03608111

Last Updated: 2018-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-01

Study Completion Date

2017-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Impairment in the control of balance is a common problem among elderly patients especially whom with osteoarthritis (OA).

Aim: The aim of this study was to compare the effects of single-task and dual-task training on balance performance in the elderly osteoarthritic patients with balance impairment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fifty elderly osteoarthritic patients with balance impairment were included into this study. Patients were randomly assigned to single task balance training (Group 1) or dual-task balance training (Group 2) groups. Balance activities were given to both groups for 3 times a week for 4 weeks. Patients in group 2 also performed cognitive tasks simultaneously with these exercises. Patients were evaluated with Berg balance scale (BBS), kinesthetic ability trainer (KAT 2000) static and dynamic scores, timed up and go test (TUTG) and walking speed for single and dual tasks, number of stopping and Activities Specific Balance Confidence (ABC) Scale at the baseline and at the end of 4 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Balance Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

single task balance training

Group Type ACTIVE_COMPARATOR

single task balance training

Intervention Type OTHER

single task balance training

dual task balance training

Intervention Type OTHER

dual task balance training

dual task balance training

Group Type ACTIVE_COMPARATOR

single task balance training

Intervention Type OTHER

single task balance training

dual task balance training

Intervention Type OTHER

dual task balance training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

single task balance training

single task balance training

Intervention Type OTHER

dual task balance training

dual task balance training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* included age ≥65, able to walk 10 m, no neurological or musculoskeletal diagnosis, met the criteria of balance impairment, and scored \>19 on the mini mental state examination.

Exclusion Criteria

* neurologic or musculoskeletal diagnosis such as stroke, orthopedic involvement, significant visual and auditory impairments, severe vitamin B12 deficiency and sedative drug use.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ufuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ASLIHAN UZUNKULAOGLU

Ufuk University

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

30112015-5.

Identifier Type: -

Identifier Source: org_study_id